tender for supply of allopathic drugs for the year 2026-28- , cream betamethasone (dipropionate) ip 0.05% w/w, 30gmb13:e45 tube , cap. indomethacin ip 25mg , solution povidone iodine ip 10%w/v, 500ml bottle , syrup levocetrizine ip 2.5mg/ml, 60ml bottle , inj. docetexel 80mg/2ml, per vial , inj. epirubicin 50mg/vial, vial , tab. gefitinib 250mg, 1x30 tab bottle, per tab , tab. voriconazole i.p 200 mg , cap. gabapentitine 300 mg , tab. montelukast 10mg , tab. olmesartan 20mg , tab. vitamin-c 500mg (chewing tablet) , glycerol oral liquid, 500 ml bottle , liquid paraffin, per 500ml bottle , tablet enzalutamide 150 mg , ini. azacitidine 100 mg , tablet pazopanib 500 mg , inj. octreotide 30 mg , tablet desatanib 50 mg , tablet lenvatinib 8 mg , tablet cabozanitinib 40mg , inj. lipid docetaxel 100 mg , inj. lipid docetaxel 20 mg , nano-albumin bound paclitaxel , tab. metformin hydrochloride extended- release 850mg , tab. metformin hydrochloride special repair 1000 mg , human coagulation factor ix freeze dried 1200 iu-ip , inj. docetaxel 20mg/ml, 4ml vial , inj. epirubicin 50mg/vial, vial , tab. gefitinib 250mg, 1x30 tab bottle, per tab , inj. immunoglobulin 5% 100ml bottle , inj. immunoglobulin 10% 100ml bottle , anti rabies monoclonal antibody (human) injection 100iu per 2.5 ml vial , inj. paracetamol im 500mg vial surfactant free , pertuzumab+trastuzumab injection 600mg+600mg in10ml , pertuzumab+trastuzumab injection 1200mg/600mg in 15ml , atezolizumab injection 1200 mg/ 20 ml , obinutuzumab injection 1000 mg/ 40 ml , pertuzumab injection 420mg/14 ml